ישראל - עברית - Ministry of Health

takeda israel ltd - dexlansoprazole - קפסולות בשחרור מושהה - dexlansoprazole 60 mg - dexlansoprazole

ישראל - עברית - Ministry of Health

takeda israel ltd - vedolizumab - תמיסה להזרקה - vedolizumab 158.8 mg / 1 ml - vedolizumab

ישראל - עברית - Ministry of Health

takeda israel ltd - human normal immunoglobulin - תמיסה לאינפוזיה - human normal immunoglobulin 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm.

ישראל - עברית - Ministry of Health

takeda israel ltd - darvadstrocel - תרחיף להזרקה - darvadstrocel 5000000 cells/ml - darvadstrocel

ישראל - עברית - Ministry of Health

takeda israel ltd - brigatinib - טבליות מצופות פילם - brigatinib 30 mg - brigatinib

ישראל - עברית - Ministry of Health

takeda israel ltd - brigatinib - טבליות מצופות פילם - brigatinib 90 mg - brigatinib

ישראל - עברית - Ministry of Health

takeda israel ltd - lanadelumab - תמיסה להזרקה - lanadelumab 150 mg/ml - lanadelumab

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.